BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19332249)

  • 1. Management of advanced-stage and recurrent endometrial cancer.
    Ray M; Fleming G
    Semin Oncol; 2009 Apr; 36(2):145-54. PubMed ID: 19332249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH;
    Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
    Hogberg T
    Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
    Deppe G; Baumann P; Munkarah A
    Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
    Sehouli J; Koensgen D; Oskay-Ozcelik G; Mustea A
    Crit Rev Oncol Hematol; 2008 Sep; 67(3):204-12. PubMed ID: 18407513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment options for endometrial cancer.
    Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in endometrial cancer.
    Obel JC; Friberg G; Fleming GF
    Clin Adv Hematol Oncol; 2006 Jun; 4(6):459-68. PubMed ID: 16981669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for high-risk early-stage endometrial cancer.
    Kodama J; Seki N; Hiramatsu Y
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
    Modesitt SC; Tian C; Kryscio R; Thigpen JT; Randall ME; Gallion HH; Fleming GF;
    Gynecol Oncol; 2007 Apr; 105(1):59-65. PubMed ID: 17150247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
    Dellinger TH; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer].
    Misawa A; Nagao M; Kushimoto T; Yasuda M
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal therapy and chemotherapy of endometrial cancer].
    Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
    Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for advanced endometrial carcinoma.
    Dizon DS
    Gynecol Oncol; 2010 May; 117(2):373-81. PubMed ID: 20223510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any place for cytotoxic chemotherapy in endometrial cancer?
    Steer C; Harper P
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):447-67. PubMed ID: 11476565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?
    Boren TP; Miller DS
    Womens Health (Lond); 2010 Nov; 6(6):789-95. PubMed ID: 21118038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of early-stage endometrial cancer.
    Lu KH
    Semin Oncol; 2009 Apr; 36(2):137-44. PubMed ID: 19332248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of cancer chemotherapy on patients with recurrent endometrial carcinoma].
    Kakinoki S; Takizawa K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():365-9. PubMed ID: 15535269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.